{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:00:40Z","timestamp":1766023240913,"version":"3.48.0"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Dis"],"DOI":"10.62347\/wjwp6904","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:19:18Z","timestamp":1747178358000},"page":"149-155","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the prevalence, in-hospital mortality and readmission rates amongst pulmonary vs cardiac sarcoidosis patients: insights from a nationwide registry"],"prefix":"10.62347","volume":"15","author":[{"given":"Shivang","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S&#xE8","year":"2021","unstructured":"Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, Boussel L, Calender A, Androdias G, Valeyre D and El Jammal T. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells 2021; 10: 766.","journal-title":"Cells"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","unstructured":"Rossides M, Darlington P, Kullberg S and Arkema EV. Sarcoidosis: epidemiology and clinical insights. J Intern Med 2023; 293: 668-680.","journal-title":"J Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and treatment of pulmonary sarcoidosis: a review","volume":"327","author":"Belperio","year":"2022","unstructured":"Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R and Lynch JP 3rd. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA 2022; 327: 856-867.","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review","volume":"76","author":"Trivieri","year":"2020","unstructured":"Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, Baughman R, Fayad ZA and Judson MA. Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol 2020; 76: 1878-1901.","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS Clinical Statement on pulmonary sarcoidosis","volume":"76","author":"Thillai","year":"2021","unstructured":"Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho LP, Kouranos V, Patterson K, Screaton NJ, Whight J and Wells AU. BTS Clinical Statement on pulmonary sarcoidosis. Thorax 2021; 76: 4-20.","journal-title":"Thorax"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","unstructured":"Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ and Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest 2015; 147: 438-449.","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","unstructured":"Kirkil G, Lower EE and Baughman RP. Predictors of mortality in pulmonary sarcoidosis. Chest 2018; 153: 105-113.","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietilä-Effati P, Utrianen S and Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-632.","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstr&#xF6","year":"2019","unstructured":"Ekström K, Lehtonen J, Nordenswan HK, Mäyränpää MI, Räisänen-Sokolowski A, Kandolin R, Simonen P, Pietilä-Effati P, Alatalo A, Utriainen S, Rissanen TT, Haataja P, Kokkonen J, Vihinen T, Miettinen H, Kaikkonen K, Kerola T and Kupari M. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J 2019; 40: 3121-3128.","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.31083\/j.rcm.2020.03.102","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"21","author":"Markatis","year":"2020","unstructured":"Markatis E, Afthinos A, Antonakis E and Papanikolaou IC. Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med 2020; 21: 321-338.","journal-title":"Rev Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM and Kim RJ. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-1977.","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"KJ","year":"1978","unstructured":"Silverman KJ, Hutchins GM and Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-1211.","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-195202000-00001","article-title":"A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital","volume":"31","author":"Longcope","year":"1952","unstructured":"Longcope WT and Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952; 31: 1-132.","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D and Brown KK. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011; 183: 1524-1530.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/eurheartj\/ehw328","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2016","unstructured":"Birnie DH, Kandolin R, Nery PB and Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 2016; 38: 2663-2670.","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI and Yamashina A; Japanese Circulation Society Joint Working Group. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J 2019; 83: 2329-2388.","journal-title":"Circ J"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Cheng RK, Kittleson MM, Beavers CJ, Birnie DH, Blankstein R, Bravo PE, Gilotra NA, Judson MA, Patton KK and Rose-Bovino L; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation 2024; 149: e1197-e1216.","DOI":"10.1161\/CIR.0000000000001240"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.jcmg.2022.05.015","article-title":"Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis","volume":"15","author":"Rojulpote","year":"2022","unstructured":"Rojulpote C, Bhattaru A, Jean C, Adams SL, Patel V, Vidula MK, Selvaraj S, Dubroff J, Peyster E, Clancy CB, Patterson K, Marchlinski FE, Rossman M, Goldberg L and Bravo PE. Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2022; 15: 1944-1955.","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Rojulpote C, Bhattaru A, Patil S, Vidula MK, Peyster EG, Frankel DS, Nazarian S, Litt HI, Goldberg LR, Marchlinski FE and Bravo PE. Abstract 11404: phenotyping cardiac sarcoidosis with PET\/MR: imaging characteristics, treatment response, and outcomes of isolated cardiac sarcoidosis versus extra-cardiac sarcoidosis with cardiac involvement. Circulation 2022; 146: A11404.","DOI":"10.1161\/circ.146.suppl_1.11404"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1601290","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS and Matteson EL. Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. Eur Respir J 2017; 49: 1601290.","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2020.06.038","article-title":"Long-term adverse cardiac outcomes in patients with sarcoidosis","volume":"76","author":"Yafasova","year":"2020","unstructured":"Yafasova A, Fosbol EL, Schou M, Gustafsson F, Rossing K, Bundgaard H, Lauridsen MD, Kristensen SL, Torp-Pedersen C, Gislason GH, Kober L and Butt JH. Long-term adverse cardiac outcomes in patients with sarcoidosis. J Am Coll Cardiol 2020; 76: 767-777.","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Rojulpote C, Gonuguntla K, Patil S, Karambelkar P, Gade A and Bhattaru A. Predictors of in-hospital mortality in patients with sarcoidosis with cardiomyopathy. Chest 2020; 158: A125.","DOI":"10.1016\/j.chest.2020.08.147"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Gonuguntla K, Patil SP, Rojulpote C, Borja ZE and Bravo PE. Sarcoid heart disease: rates of arrhythmias, implantable cardiac devices and endomyocardial biopsy. Eur Heart J 2020; 41.","DOI":"10.1093\/ehjci\/ehaa946.2133"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Ribeiro Neto ML, Jellis C, Hachamovitch R, Wimer A, Highland KB, Sahoo D, Khabbaza JE, Pande A, Bindra A, Southern BD, Parambil JG, Callahan TD, Joyce E and Culver DA. Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: is it time to regroup? Am Heart J 2020; 223: 106-109.","DOI":"10.1016\/j.ahj.2020.02.008"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","unstructured":"Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C, Chrispin J, Sharp M, Kasper EK, Chen ES, Blankstein R, Cooper LT, Joyce E and Sheikh FH. Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail 2022; 28: 113-132.","journal-title":"J Card Fail"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","unstructured":"Fussner LA, Karlstedt E, Hodge DO, Fine NM, Kalra S, Carmona EM, Utz JP, Isaac DL and Cooper LT. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres. Eur J Heart Fail 2018; 20: 1713-1720.","journal-title":"Eur J Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/CIRCULATIONAHA.123.066962","article-title":"End-stage heart failure in cardiac sarcoidosis","volume":"149","author":"Velikanova","year":"2024","unstructured":"Velikanova D, Poyhonen P, Lehtonen J, Simonen P, Uusitalo V, Vihinen T, Kaikkonen K, Haataja P, Kerola T, Rissanen TT, Vepsalainen V, Alatalo A, Pietila-Effati P and Kupari M. End-stage heart failure in cardiac sarcoidosis. Circulation 2024; 149: 885-887.","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.18553\/jmcp.2017.17203","article-title":"High-cost sarcoidosis patients in the United States: patient characteristics and patterns of health care resource utilization","volume":"23","author":"Rice","year":"2017","unstructured":"Rice JB, White A, Lopez A and Nelson WW. High-cost sarcoidosis patients in the United States: patient characteristics and patterns of health care resource utilization. J Manag Care Spec Pharm 2017; 23: 1261-1269.","journal-title":"J Manag Care Spec Pharm"}],"container-title":["American Journal of Cardiovascular Disease"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcd\/15\/2\/ajcd0162381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:41Z","timestamp":1766022941000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcd\/15\/2\/ajcd0162381.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/wjwp6904","relation":{},"ISSN":["2160-200X"],"issn-type":[{"type":"electronic","value":"2160-200X"}],"subject":[],"published":{"date-parts":[[2025]]}}}